What Happened?
Madison, WI-based Flugen Appointed Paul Radspinner as Chief Executive Officer
About the Company
Flugen is driving the development of a universal flu vaccine to advance human health.
About the Person
Mr. Radspinner has over 15 years of experience in management roles overseeing international pharmaceutical operations, marketing and business development with Eli Lilly and Company and the Wisconsin Alumni Research Foundation (WARF) where he managed its pharmaceuticals portfolio including its most profitable and important therapeutic area- vitamin D analogs. Most recently, Mr. Radspinner took on the role of Vice President of Business Development for Deltanoid Pharmaceuticals, Inc., a Madison based biopharmaceutical company. Mr. Radspinner holds a B.A. from Wabash College and an MBA from the Kellogg Graduate School of Management at Northwestern University.
Info Source
Press Release
Short Profile